Trending...
- 2025 Packaging State of the Industry: U.S. Expands, Canada Maintains Strong Base
- Phinge to Offer Its Businesses & Third-Party Platforms Free Management Tools Which Could Replace Their Need For Costly Business Intelligence Products
- Green Office Partner Named #1 Best Place to Work in Chicago by Crain's for 2025
LAS VEGAS, Dec. 31, 2021 /PRNewswire/ -- iMediSync is launching their revolutionary, comprehensive, early mental health diagnostics and remote care solution, iSyncWave™, after 10-years of research and clinical trials.
iMediSync will offer free 10-minute brain screening sessions throughout their press conference and VIP Tour Program at CES 2022. CES attendees can expect a complete analysis report of their measured EEG (brainwaves) and HRV (heart rate variability). In just ten minutes, early signs of multiple mental conditions and impairments of their brains that are not detectable by conventional methods will be analyzed (such as Alzheimer's dementia). Click here to learn more.
When: January 5th at the iMediSync booth and the CES provided conference room on January 6th.
Who should attend: Media, CES attendees interested in AI health technologies, healthcare professionals, researchers, and pharma companies interested in brain reaction to intervention.
More on nvtip.com
Where: Health & Wellness zone, Tech East-North Hall of Las Vegas Convention Center. LVCC, North Hall - 8455. Las Vegas Westgate Resort & Casino. 3000 Paradise Rd, Las Vegas, NV 89109.
ABOUT iMediSync, Inc.
HEADQUARTERED in Seoul, Korea iMediSync was founded by CEO, Dr. Seung Wan Kang. iMediSync has developed an AI-driven early detection and therapeutic platform for optimal brain health. iMediSync launched its first solution to detect Mild Cognitive Impairment (early stage of Alzheimer's Disease) based on its proprietary EEG database in Korea and other parts of the world. Clinical trials with multicenter hospitals confirmed a 90%+ accuracy for its solution. The vision of iMediSync is to develop early-detecting biomarkers for challenging neurological disorders and diseases such as COMA, Parkinson's, ADHD, Depression, etc. For more information, visit www.imedisync.com.
Media Contact:
Photos and interviews can be arranged per your request.
Aditi Maheshwari
(415) 802-4230
[email protected]
SOURCE iMediSync
iMediSync will offer free 10-minute brain screening sessions throughout their press conference and VIP Tour Program at CES 2022. CES attendees can expect a complete analysis report of their measured EEG (brainwaves) and HRV (heart rate variability). In just ten minutes, early signs of multiple mental conditions and impairments of their brains that are not detectable by conventional methods will be analyzed (such as Alzheimer's dementia). Click here to learn more.
When: January 5th at the iMediSync booth and the CES provided conference room on January 6th.
Who should attend: Media, CES attendees interested in AI health technologies, healthcare professionals, researchers, and pharma companies interested in brain reaction to intervention.
More on nvtip.com
- Agemin Unveils Breakthrough AI Model for Biometric Age Estimation, Setting New Standards in Online Child Safety
- Strategic Partnerships with Defiant Space Corp and Emtel Energy USA Powerfully Enhance Solar Tech Leader with NASA Agreements: Ascent Solar $ASTI
- 120% Revenue Surge with Four Straight Profitable Quarters Signal a Breakout in the Multi-Billion Dollar Homebuilding Market: Innovative Designs $IVDN
- Leading Venture Capital Firms Recognize Wzzph Exchange's Technical Architecture and Security Framework as Industry Benchmark
- DivX Unveils Major DivX Software Update: Seamless Video Sharing and Customizable Playback Now Available
Where: Health & Wellness zone, Tech East-North Hall of Las Vegas Convention Center. LVCC, North Hall - 8455. Las Vegas Westgate Resort & Casino. 3000 Paradise Rd, Las Vegas, NV 89109.
ABOUT iMediSync, Inc.
HEADQUARTERED in Seoul, Korea iMediSync was founded by CEO, Dr. Seung Wan Kang. iMediSync has developed an AI-driven early detection and therapeutic platform for optimal brain health. iMediSync launched its first solution to detect Mild Cognitive Impairment (early stage of Alzheimer's Disease) based on its proprietary EEG database in Korea and other parts of the world. Clinical trials with multicenter hospitals confirmed a 90%+ accuracy for its solution. The vision of iMediSync is to develop early-detecting biomarkers for challenging neurological disorders and diseases such as COMA, Parkinson's, ADHD, Depression, etc. For more information, visit www.imedisync.com.
Media Contact:
Photos and interviews can be arranged per your request.
Aditi Maheshwari
(415) 802-4230
[email protected]
SOURCE iMediSync
Filed Under: Business
0 Comments
Latest on nvtip.com
- Bridging Traditional Finance and Web3 Innovation: BLFCW Announces Strategic Vision for Regulated Web3 Economy
- NKSCX Responds to "Coordinated Smear Campaign" as Anonymous Critics Emerge Following Regulatory Milestones
- Broadway Gala Honored Also an Italian
- $ONI Listed on MEXC as ONINO Powers Europe's Tokenization Engine Into Public Platform Launch
- AZETHIO Crypto Exchange Whitepaper Reveals MPC-Secured Infrastructure Processing 1.2 Million Transactions Per Second
- CELOXFI Platform Demonstrates Advanced Security Architecture and Regulatory Framework
- Work 365 Launches PV 3.0: The Keystone Power App for Microsoft CSPs
- Local consultant shows small businesses how to turn red tape into real money
- Tour Napa Like a Local: Vines of Napa Valley Wine Passport AKA Vine Pass Unlocks Hidden Gems
- From Casitas to Communities: 200+ BOXABL Units in the Works Since May 2025
- Dental Surgical Center Accepts Sedation Patients with Medicaid for MD, WV, PA and DC
- Sloan's Lake Dental Launches New Website to Enhance Patient Experience and Access to Modern Dental Care
- Only 3 Weeks Left till the Start of the OpenSSL Conference 2025
- ENTOUCH Completes $50 million Funding Round
- Teaming Agreement with Emtel Energy USA to Advance Thin-Film PV Energy Storage Capabilities; NASA agreements for Solar Space Tech; Ascent Solar $ASTI
- Nebuvex Acknowledges Platform "Too Secure" for Anonymous Traders; Institutional Investors Disagree
- From Tokyo to Berlin: FreeTo.Chat Unites Cultures with the World's First Confession VRX — EmojiStream™
- Visier's Vee for Microsoft Copilot Named a Top HR Product of the Year by HR Executive
- AZETHIO Launches Multi-Million Dollar User Protection Initiative Following Unprecedented Platform Growth
- Matecrypt Observes South American Cryptocurrency Adoption Surge Amid Economic Shifts